Assessing the Performance of 7-Day vs 1-Day Packaging for Small Quantity Lipid-Based Nutrient Supplements in Ghana (SQLNS:7D-1D Comparison)
SQLNS:7Dv1D
1 other identifier
interventional
505
1 country
1
Brief Summary
This cluster-randomized crossover trial evaluates the impact of two different packaging formats for small-quantity lipid-based nutrient supplements (SQ-LNS) on adherence and acceptability among caregivers of young children in Northern Ghana. SQ-LNS are a proven intervention for reducing child malnutrition, but optimizing packaging formats may improve adherence and scalability. Sixteen health facilities participating in growth monitoring services will each receive both formats: a 1-day sachet (20g daily) and a 7-day bulk container (140g weekly), with the order of delivery randomized. Each packaging format will be distributed for one month before cross-over. The primary outcomes are adherence (measured through caregiver self-report and sachet counts) and acceptability (assessed via caregiver interviews). Secondary outcomes include caregiver preference, ease of use, and qualitative insights into feeding practices, beliefs, and packaging usability. This implementation research study uses a convergent mixed-methods design, integrating quantitative adherence and acceptability data with in-depth interviews and structured observations to inform real-world program implementation. Findings will guide policy and program decisions for integrating SQ-LNS into child health platforms in Ghana and other low-resource settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 5, 2025
CompletedFirst Posted
Study publicly available on registry
August 19, 2025
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
Study Completion
Last participant's last visit for all outcomes
December 1, 2026
July 10, 2026
July 1, 2026
3 months
August 5, 2025
July 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adherence
Adherence will be defined as the percentage of the 28-day dose of small quantity lipid-based nutrient supplements (SQ-LNS) consumed, measured using a triangulated approach that combines caregiver report with returned-sachet counts and residual-sachet weighing.
Measured twice per participant: at the end of the first 1-month phase and at the end of the second 1-month phase
Secondary Outcomes (2)
Caregiver acceptability/usability
Measured twice per participant: at the end of the first 1-month phase and at the end of the second 1-month phase
Caregiver experience with SQ-LNS
At the end of each 1-month crossover period (following each intervention phase)
Study Arms (2)
SQ-LNS 1-day packaging first, followed by 7-day packaging
ACTIVE COMPARATORSQ-LNS 1-day packaging first, followed by 7-day packaging
SQ-LNS 7-day packaging first, followed by 1-day packaging
EXPERIMENTALSQ-LNS 7-day packaging first, followed by 1-day packaging
Interventions
All caregivers will receive 2 months of SQ-LNS in this cross-over design. Half of the participants will be randomized to receive the 7-day packaging first, and half will receive the 1-day packaging first.
Eligibility Criteria
You may qualify if:
- Primary caregiver of a child aged 6-24 months attending growth monitoring and promotion (GMP) services at one of the participating health facilities
- Willing and able to provide informed consent
- Plans to remain in the area for the duration of the study period
- Agrees to participate in surveys and/or interviews related to supplement use
You may not qualify if:
- Caregiver of a child with a diagnosed severe illness requiring hospitalization
- Caregiver under the age of 18
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston University Charles River Campuslead
- University of Ghanacollaborator
- Edesia Nutritioncollaborator
Study Sites (1)
Sixteen health facilities in the Northern Region of Ghana (exact sites TBD)
Tamale, Ghana
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lindsey Locks, ScD
Bostson University Charles River Campus
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2025
First Posted
August 19, 2025
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
July 10, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share